178
Views
62
CrossRef citations to date
0
Altmetric
Original Research

iRGD-modified lipid–polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability

, , , , , , , , & show all
Pages 4147-4162 | Published online: 01 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Jingbin Huang, Wenjing Lai, Qing Wang, Qin Tang, Changpeng Hu, Min Zhou, Fengling Wang, Dandan Xie, Qian Zhang, Wuyi Liu, Zhe Zhang & Rong Zhang. (2021) Effective Triple-Negative Breast Cancer Targeted Treatment Using iRGD-Modified RBC Membrane-Camouflaged Nanoparticles. International Journal of Nanomedicine 16, pages 7497-7515.
Read now
Qiang Yang, Yanghao Zhou, Jin Chen, Ning Huang, Zhigang Wang & Yuan Cheng. (2021) Gene Therapy for Drug-Resistant Glioblastoma via Lipid-Polymer Hybrid Nanoparticles Combined with Focused Ultrasound. International Journal of Nanomedicine 16, pages 185-199.
Read now
Leila Razavi, Heidar Raissi, Hassan Hashemzadeh & Farzaneh Farzad. (2021) Molecular insights into the loading and dynamics of anticancer drugs on silicene and folic acid-conjugated silicene nanosheets: DFT calculation and MD simulation. Journal of Biomolecular Structure and Dynamics 39:11, pages 3892-3899.
Read now
Mingzhuo Cao, Mengling Zhan, Zheng Wang, Zeqian Wang, Xiu-Min Li & Mingsan Miao. (2020) Development of an Orally Bioavailable Isoliquiritigenin Self-Nanoemulsifying Drug Delivery System to Effectively Treat Ovalbumin-Induced Asthma. International Journal of Nanomedicine 15, pages 8945-8961.
Read now
Jie Zhao, Bin Wen, Zhengbing Tan, Xinyan Li & Xuesong Zhang. (2020) iRGD-targeted hybrid nanoparticles reverses multi-drug resistant to effectively combat liver cancer. Journal of Drug Targeting 28:10, pages 1063-1070.
Read now
Anubhab Mukherjee, Ariana K Waters, Pranav Kalyan, Achal Singh Achrol, Santosh Kesari & Venkata Mahidhar Yenugonda. (2019) Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives. International Journal of Nanomedicine 14, pages 1937-1952.
Read now
Zhen Zhang, Hanqing Qian, Jie Huang, Huizi Sha, Hang Zhang, Lixia Yu, Baorui Liu, Dong Hua & Xiaoping Qian. (2018) Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment. International Journal of Nanomedicine 13, pages 4961-4975.
Read now

Articles from other publishers (54)

Richa Dave, Rashmin Patel & Mrunali Patel. (2023) Hybrid lipid-polymer nanoplatform: A systematic review for targeted colorectal cancer therapy. European Polymer Journal 186, pages 111877.
Crossref
Yan Wang, Chen Zhang, Meng Xiao, Kumar Ganesan, Fei Gao, Qingqing Liu, Zhen Ye, Yue Sui, Feng Zhang, Kunhua Wei, Yaobin Wu, Jianmin Wu, Bing Du, Cong Xu, Yan Li, Peng Li, Jinming Zhang & Jianping Chen. (2023) A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer. Journal of Drug Delivery Science and Technology 79, pages 103922.
Crossref
Naveen Rajana, Aare Mounika, Padakanti Sandeep Chary, Valamla Bhavana, Anuradha Urati, Dharmendra Khatri, Shashi Bala Singh & Neelesh Kumar Mehra. (2022) Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer. Journal of Controlled Release 352, pages 1024-1047.
Crossref
Zerong Pei, Shuting Chen, Liqin Ding, Jingbo Liu, Xinyi Cui, Fengyun Li & Feng Qiu. (2022) Current perspectives and trend of nanomedicine in cancer: A review and bibliometric analysis. Journal of Controlled Release 352, pages 211-241.
Crossref
Drishti Panjwani, Deepak Mishra, Shruti Patel, Viral Patel, Abhay Dharamsi & Asha Patel. (2022) A Perspective on EGFR and Proteasome-based Targeted Therapy for Cancer. Current Drug Targets 23:15, pages 1406-1417.
Crossref
Hardeep Singh Tuli, Vivek Kumar Garg, Jinit K Mehta, Ginpreet Kaur, Ranjan K Mohapatra, Kuldeep Dhama, Katrin Sak, Ajay Kumar, Mehmet Varol, Diwakar Aggarwal, Uttpal Anand, Jagjit Kaur, Ross Gillan, Gautam Sethi & Anupam Bishayee. (2022) Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects. OncoTargets and Therapy Volume 15, pages 1419-1448.
Crossref
Sindhoor S. M.N. Raghavendra Naveen, GSN Koteswara Rao, Gopika Gopan, Hitesh Chopra, Moon Nyeo Park, Mohammed Merae Alshahrani, Jobin Jose, Talha Bin Emran & Bonglee Kim. (2022) A spotlight on alkaloid nanoformulations for the treatment of lung cancer. Frontiers in Oncology 12.
Crossref
Zeinabosadat Davoodi & Fatemeh Shafiee. (2022) Internalizing RGD, a great motif for targeted peptide and protein delivery: a review article. Drug Delivery and Translational Research 12:10, pages 2261-2274.
Crossref
Feng Zhang, Kumar Ganesan, Qingqing Liu & Jianping Chen. (2022) A Review of the Pharmacological Potential of Spatholobus suberectus Dunn on Cancer. Cells 11:18, pages 2885.
Crossref
Mohamed Hamdi, Enas Elmowafy, Hend Mohamed Abdel-Bar, Akram M. ElKashlan, Khuloud T. Al-Jamal & Gehanne A.S. Awad. (2022) Hyaluronic acid-entecavir conjugates-core/lipid-shell nanohybrids for efficient macrophage uptake and hepatotropic prospects. International Journal of Biological Macromolecules 217, pages 731-747.
Crossref
Md. Mominur Rahman, Md. Rezaul Islam, Shopnil Akash, Md. Harun-Or-Rashid, Tanmay Kumar Ray, Md. Saidur Rahaman, Mahfuzul Islam, Fazilatunnesa Anika, Md. Kawser Hosain, Farjana Islam Aovi, Hassan A. Hemeg, Abdur Rauf & Polrat Wilairatana. (2022) Recent advancements of nanoparticles application in cancer and neurodegenerative disorders: At a glance. Biomedicine & Pharmacotherapy 153, pages 113305.
Crossref
Bhanu P. Sahu, Rinku Baishya, Jyoti Lakshmi Hatiboruah, Damiki Laloo & Nikhil Biswas. (2022) A comprehensive review on different approaches for tumor targeting using nanocarriers and recent developments with special focus on multifunctional approaches. Journal of Pharmaceutical Investigation 52:5, pages 539-585.
Crossref
Jianman Wang, Hongjin Chen, Tao Guo, Ping Yue, Tianbao Qian, Xiangyu Zeng, Yali Luo, Jiangmin Li, Lijing Teng, Qingyu Liu, Liang Hong, Zijiang Yu & Zuquan Hu. (2022) Isoliquiritigenin Nanoemulsion Preparation by Combined Sonication and Phase-Inversion Composition Method: In Vitro Anticancer Activities. Bioengineering 9:8, pages 382.
Crossref
Mazhar Salim Al-Zoubi & Raed M. Al-Zoubi. (2022) Nanomedicine tactics in cancer treatment: Challenge and hope. Critical Reviews in Oncology/Hematology 174, pages 103677.
Crossref
Nitin Gupta, Virendra Yadav & Rakesh Patel. (2022) A Brief Review of the Essential Role of Nanovehicles for Improving the Therapeutic Efficacy of Pharmacological Agents Against Tumours. Current Drug Delivery 19:3, pages 301-316.
Crossref
Rama Rao Malla, Satyalakshmi Siragam, Vasudha Dadi & Balachandrika Seetini. (2022) Natural Chalcones and Their Derivatives Target the Tumor Microenvironment in Colon Cancer. Critical Reviews in Immunology 42:6, pages 27-39.
Crossref
Saurabh Shah, Paras Famta, Rajeev Singh Raghuvanshi, Shashi Bala Singh & Saurabh Srivastava. (2022) Lipid polymer hybrid nanocarriers: Insights into synthesis aspects, characterization, release mechanisms, surface functionalization and potential implications. Colloid and Interface Science Communications 46, pages 100570.
Crossref
Ayeskanta Mohanty, Saji Uthaman & In-Kyu Park. 2022. Stimuli-Responsive Nanocarriers. Stimuli-Responsive Nanocarriers 319 349 .
Ranjit De, Manoj Kumar Mahata, Yo Han Song & Kyong-Tai Kim. 2022. Pharmaceutical Nanobiotechnology for Targeted Therapy. Pharmaceutical Nanobiotechnology for Targeted Therapy 227 254 .
Izolda Kántor, Diana Dreavă, Anamaria Todea, Francisc Péter, Zoltán May, Emese Biró, György Babos & Tivadar Feczkó. (2021) Co-Entrapment of Sorafenib and Cisplatin Drugs and iRGD Tumour Homing Peptide by Poly[ε-caprolactone-co-(12-hydroxystearate)] Copolymer. Biomedicines 10:1, pages 43.
Crossref
Meisi Lin, Lingling Dong, Qiyan Chen, Haiting Xu, Xiaoqin Han, Ruifeng Luo, Xiulan Pu, Shanshan Qi, Wenbiao Nie, Meilin Ma, Yitao Wang, Fei Gao & Jinming Zhang. (2021) Lentinan-Based Oral Nanoparticle Loaded Budesonide With Macrophage-Targeting Ability for Treatment of Ulcerative Colitis. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Ruifeng Luo, Meisi Lin, Chaomei Fu, Jinming Zhang, Qiyan Chen, Chen Zhang, Jinfeng Shi, Xiulan Pu, Linlin Dong, Haiting Xu, Naijing Ye, Jiayi Sun, Dasheng Lin, Bin Deng, Arlene McDowell, Shu Fu & Fei Gao. (2021) Calcium pectinate and hyaluronic acid modified lactoferrin nanoparticles loaded rhein with dual-targeting for ulcerative colitis treatment. Carbohydrate Polymers 263, pages 117998.
Crossref
Yong Zhuang, Yiye Zhao, Bingyue Wang, Qi Wang, Tiange Cai & Yu Cai. (2021) Strategies for Preparing Different Types of Lipid Polymer Hybrid Nanoparticles in Targeted Tumor Therapy. Current Pharmaceutical Design 27:19, pages 2274-2288.
Crossref
Phebee Angeline, Aswathi Thomas, Sri Amruthaa Sankaranarayanan & Aravind Kumar Rengan. (2021) Effect of pH on Isoliquiritigenin (ISL) fluorescence in lipo- polymeric system and metallic nanosystem. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 252, pages 119545.
Crossref
Ejaj Ahmad, Asgar Ali, Munazza Tamkeen Fatima, Nimisha, Apurva, Arun Kumar, Mamta P. Sumi, Real Sumayya Abdul Sattar, Bhawna Mahajan & Sundeep Singh Saluja. (2021) Ligand decorated biodegradable nanomedicine in the treatment of cancer. Pharmacological Research 167, pages 105544.
Crossref
Francesca Persano, Giuseppe Gigli & Stefano Leporatti. (2021) Lipid-polymer hybrid nanoparticles in cancer therapy: current overview and future directions. Nano Express 2:1, pages 012006.
Crossref
Hong Pan, Hongyan Shi, Peng Fu, Pengfei Shi & Jianyuan Yang. (2021) Liposomal Dendritic Cell Vaccine in Breast Cancer Immunotherapy. ACS Omega 6:5, pages 3991-3998.
Crossref
Sabrina Bochicchio, Gaetano Lamberti & Anna Angela Barba. (2021) Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies. Pharmaceutics 13:2, pages 198.
Crossref
Nilesh Malavia, Kaushik Kuche, Rohan Ghadi & Sanyog Jain. (2021) A bird's eye view of the advanced approaches and strategies for overshadowing triple negative breast cancer. Journal of Controlled Release 330, pages 72-100.
Crossref
Kai-Lee Wang, Ying-Chun Yu & Shih-Min Hsia. (2021) Perspectives on the Role of Isoliquiritigenin in Cancer. Cancers 13:1, pages 115.
Crossref
Viney Chawla, Pooja A. Chawla & Anju Dhiman. 2021. Advanced Drug Delivery Systems in the Management of Cancer. Advanced Drug Delivery Systems in the Management of Cancer 343 350 .
Yang Yang, Xin Jin, Xinyi Jiao, Jinjing Li, Liuyi Liang, Yuanyuan Ma, Rui Liu & Zheng Li. (2020) Advances in Pharmacological Actions and Mechanisms of Flavonoids from Traditional Chinese Medicine in Treating Chronic Obstructive Pulmonary Disease. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-10.
Crossref
Mao Mao, Senfeng Liu, Yiming Zhou, Gonghe Wang, Jianping Deng & Lei Tian. (2020) Nanostructured lipid carrier delivering chlorins e6 as in situ dendritic cell vaccine for immunotherapy of gastric cancer. Journal of Materials Research 35:23-24, pages 3257-3264.
Crossref
Qin Huang, En Wang, Weigang Gu, Wencong Ma & Yifeng Zhou. (2020) Hyaluronan-coated meta-organic framework loaded with cisplatin and oleanolic acid for synergetic chemotherapy of colorectal cancer. Journal of Materials Research 35:22, pages 3106-3115.
Crossref
Ruifeng Luo, Meisi Lin, Chen Zhang, Jinfeng Shi, Siyuan Zhang, Qiyan Chen, Yichen Hu, Minyue Zhang, Jinming Zhang & Fei Gao. (2020) Genipin-crosslinked human serum albumin coating using a tannic acid layer for enhanced oral administration of curcumin in the treatment of ulcerative colitis. Food Chemistry 330, pages 127241.
Crossref
Ayeskanta Mohanty, Saji Uthaman & In-Kyu Park. (2020) Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy. Molecules 25:19, pages 4377.
Crossref
Sujin Kang, Sooyeun Lee & Soyeun Park. (2020) iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery. Polymers 12:9, pages 1906.
Crossref
Yihan Yao, Yunxiang Zhou, Lihong Liu, Yanyan Xu, Qiang Chen, Yali Wang, Shijie Wu, Yongchuan Deng, Jianmin Zhang & Anwen Shao. (2020) Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Frontiers in Molecular Biosciences 7.
Crossref
Yougan Chen, Yuanyuan Deng, Chenyao Zhu & Congming Xiang. (2020) Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles. Biomedicine & Pharmacotherapy 127, pages 110181.
Crossref
Faezeh Ghorbanizamani, Hichem Moulahoum, Figen Zihnioglu & Suna Timur. (2020) Nanohybrid carriers: the yin–yang equilibrium between natural and synthetic in biomedicine. Biomaterials Science 8:12, pages 3237-3247.
Crossref
Yan Yin, Yanpeng Li, Dan Jiang, Xianan Zhang, Wei Gao & Chunsheng Liu. (2020) De novo biosynthesis of liquiritin in Saccharomyces cerevisiae. Acta Pharmaceutica Sinica B 10:4, pages 711-721.
Crossref
Dong Chen, Longbo Cai, Yihong Guo, Junyi Chen, Qiangli Gao, Junxian Yang & Yongfa Li. (2020) Cancer Cell Membrane-Decorated Zeolitic-Imidazolate Frameworks Codelivering Cisplatin and Oleanolic Acid Induce Apoptosis and Reversed Multidrug Resistance on Bladder Carcinoma Cells. ACS Omega 5:2, pages 995-1002.
Crossref
Ting-Ting Zhao, Yu-Qing Xu, Hui-Min Hu, Hai-Bin Gong & Hai-Liang Zhu. (2019) Isoliquiritigenin (ISL) and its Formulations: Potential Antitumor Agents. Current Medicinal Chemistry 26:37, pages 6786-6796.
Crossref
José C.J.M.D.S. Menezes & Marc F. Diederich. (2019) Natural dimers of coumarin, chalcones, and resveratrol and the link between structure and pharmacology. European Journal of Medicinal Chemistry 182, pages 111637.
Crossref
Jiang Ni, Ying Sun, Jinfang Song, Yiqing Zhao, Qiufang Gao & Xia Li. (2019) Artificial Cell-Mediated Photodynamic Therapy Enhanced Anticancer Efficacy through Combination of Tumor Disruption and Immune Response Stimulation. ACS Omega 4:7, pages 12727-12735.
Crossref
Jian Liu, Qilong Wang, Michael Adu-Frimpong, Qiuyu Wei, Yujiao Xie, Kangyi Zhang, Chunmei Wei, Wen Weng, Hao Ji, Elmurat Toreniyazov, Ximing Xu & Jiangnan Yu. (2019) Preparation, in vitro and in vivo evaluation of isoliquiritigenin-loaded TPGS modified proliposomes. International Journal of Pharmaceutics 563, pages 53-62.
Crossref
Diego Tesauro, Antonella Accardo, Carlo Diaferia, Vittoria Milano, Jean Guillon, Luisa Ronga & Filomena Rossi. (2019) Peptide-Based Drug-Delivery Systems in Biotechnological Applications: Recent Advances and Perspectives. Molecules 24:2, pages 351.
Crossref
Fan Fan, Xingjuan Wu, Jiping Zhao, Ganqiao Ran, Sen Shang, Mingchuan Li & Xiaoyun Lu. (2018) A Specific Drug Delivery System for Targeted Accumulation and Tissue Penetration in Prostate Tumors Based on Microbially Synthesized PHBHHx Biopolyester and iRGD Peptide Fused PhaP. ACS Applied Bio Materials 1:6, pages 2041-2053.
Crossref
Man Zhang, Yanqing Wu, Ling Xie, Chen-Huai Teng, Fang-Fang Wu, Ke-Bin Xu, Xiong Chen, Jian Xiao, Hong-Yu Zhang & Da-Qing Chen. (2018) Isoliquiritigenin protects against blood‑brain barrier damage and inhibits the secretion of pro-inflammatory cytokines in mice after traumatic brain injury. International Immunopharmacology 65, pages 64-75.
Crossref
Jing Zhang, Peng Zhang, Qian Zou, Xiang Li, Jianjiang Fu, Ying Luo, Xinli Liang & Yi Jin. (2018) Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment. Molecules 23:11, pages 2906.
Crossref
Poulami Majumder. (2018) Integrin-Mediated Delivery of Drugs and Nucleic Acids for Anti-Angiogenic Cancer Therapy: Current Landscape and Remaining Challenges. Bioengineering 5:4, pages 76.
Crossref
Duo Yu, Xueshibojie Liu, Guangxin Zhang, Zhihui Ming & Tiejun Wang. (2018) Isoliquiritigenin Inhibits Cigarette Smoke-Induced COPD by Attenuating Inflammation and Oxidative Stress via the Regulation of the Nrf2 and NF-κB Signaling Pathways. Frontiers in Pharmacology 9.
Crossref
Marzieh Mohammadi, Sahar Taghavi, Khalil Abnous, Seyed Mohammad Taghdisi, Mohammad Ramezani & Mona Alibolandi. (2018) Hybrid Vesicular Drug Delivery Systems for Cancer Therapeutics. Advanced Functional Materials 28:36, pages 1802136.
Crossref
Muhammad Younas, Christophe Hano, Nathalie Giglioli-Guivarc'h & Bilal Haider Abbasi. (2018) Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives. RSC Advances 8:52, pages 29714-29744.
Crossref